Categories Earnings, Health Care
Earnings Summary: CooperCompanies (COO) reports Q2 2023 financial results
Medical device maker CooperCompanies (NYSE: COO) has announced financial results for the second quarter of 2023, reporting lower earnings despite an increase in revenues.
- Second-quarter revenue rose 6% year-over-year to $877.4 million; CooperVision revenue rose 6% and CooperSurgical revenue moved up 4%
- Net earnings per share, including special items, came in at $0.80, down 69% from last year’s earnings of $2.55
- Net income was $39.8 million in the April quarter, compared to $126.6 million in Q2 2022
- Adjusted earnings decreased to $3.08 per share in Q2 from $3.24 per share in the same period of last year
- The operating margin was 11%, lower than the 16% margin reported a year earlier
- Cash provided by operations totaled $124.2 million and free cash flow came in at $50.6 million
Most Popular
AbbVie Q1 2025 adjusted earnings increase on 8% revenue growth; beat estimates
Biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) announced first-quarter 2025 financial results, reporting an increase in revenue and adjusted earnings. The company reported worldwide net revenues of $13.3 billion for the
Colgate-Palmolive (CL) Q1 2025 Earnings: Key financials and quarterly highlights
Colgate-Palmolive Company (NYSE: CL) reported its first quarter 2025 earnings results today. Net sales decreased 3.1% year-over-year to $4.9 billion. Organic sales growth was 1.4%. Net income attributable to Colgate-Palmolive Company rose
Meta Platforms (META) set to report Q1 earnings. Here’s what to expect
After integrating artificial intelligence into its products, Meta Platforms, Inc. (NASDAQ: META) is investing heavily in the metaverse project. Yet, the tech giant has maintained healthy cash flows and consistently
